Alexsandro Pedro da Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alexsandro Pedro da Silva has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Aline Cavalcante de Lira
Universidade Federal de Pernambuco, Brazil
2 shared publications - Arione Vieira Do Nascimento
Federal University of Pernambuco, Brazil
2 shared publications - Kledoaldo Lima
Universidade Federal de Pernambuco, Hospital das Clínicas da UFPE. Universidade Federal de Pernambuco, Recife, PE - Brasil image/svg+xml
2 shared publications - Madi Veiga Diniz
Universidade Federal de Pernambuco, Brazil
2 shared publications - Wagner Roberto Cirilo da Silva
Federal University of Pernambuco
2 shared publications - Aderson da Silva Araújo
Department of Internal Medicine Hematology and Hemotherapy Foundation of Pernambuco Recife Pernambuco Brazil
1 shared publication
Latest Publications
- Open Access
- 16 April 2026
- Published by Wiley in British Journal of Haematology
- Vol. 208 (6) , 2203-2211
A genetic risk score based on BCL11A and HBS1L‐MYB variants predicts clinical severity in Brazilian sickle cell anaemia patients
Summary: Individuals with sickle cell anaemia (SCA) exhibit significant clinical heterogeneity influenced by several factors, especially fetal haemoglobin (HbF) levels. Variations in adult HbF levels are partly explained by the co‐inheritance of genetic variants that regulate globin expression. In this study, we investigated the association of BCL11A rs4671393, rs1427407, rs11886868 and HBS1L‐MYB rs9399137 polymorphisms with HbF levels and clinical complications in a cohort of 409 adult Brazilian SCA patients. Our findings reveal that variant alleles of all four single‐nucleotide polymorphisms (SNPs) were significantly associated with higher HbF levels. Moreover, homozygosity for the major alleles was independently associated with higher risk and cumulative incidence of stroke, avascular necrosis, leg ulcers, priapism and acute chest syndrome. Haplotype analysis with BCL11A variants was also associated with HbF and the patient's phenotype. A genetic risk score (GRS) combining the risk genotypes was significantly associated with lower HbF levels ( p < 0.0001) and increased complication risk ( p < 0.0001). A model integrating the GRS with clinical variables demonstrated superior discriminatory performance (area under the curve (AUC): 0.72) compared to models based solely on clinical factors. In summary, this study underscores the clinical relevance of HbF‐related genetic variants and supports their integration into risk stratification and personalized management strategies for SCA.
- 16 April 2026
- Published by Wiley in British Journal of Haematology
- Vol. 208 (6) , 2203-2211
Open AccessA genetic risk score based on BCL11A and HBS1L‐MYB variants predicts clinical severity in Brazilian sickle cell anaemia patients
Summary: Individuals with sickle cell anaemia (SCA) exhibit significant clinical heterogeneity influenced by several factors, especially fetal haemoglobin (HbF) levels. Variations in adult HbF levels are partly explained by the co‐inheritance of genetic variants that regulate globin expression. In this study, we investigated the association of BCL11A rs4671393, rs1427407, rs11886868 and HBS1L‐MYB rs9399137 polymorphisms with HbF levels and clinical complications in a cohort of 409 adult Brazilian SCA patients. Our findings reveal that variant alleles of all four single‐nucleotide polymorphisms (SNPs) were significantly associated with higher HbF levels. Moreover, homozygosity for the major alleles was independently associated with higher risk and cumulative incidence of stroke, avascular necrosis, leg ulcers, priapism and acute chest syndrome. Haplotype analysis with BCL11A variants was also associated with HbF and the patient's phenotype. A genetic risk score (GRS) combining the risk genotypes was significantly associated with lower HbF levels ( p < 0.0001) and increased complication risk ( p < 0.0001). A model integrating the GRS with clinical variables demonstrated superior discriminatory performance (area under the curve (AUC): 0.72) compared to models based solely on clinical factors. In summary, this study underscores the clinical relevance of HbF‐related genetic variants and supports their integration into risk stratification and personalized management strategies for SCA.
- Open Access
- 1 September 2021
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 67 (9) , 1226-1228
Vitamin D levels and SARS-CoV-2 assay results in health care workers in Brazil
- 1 September 2021
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 67 (9) , 1226-1228
Open AccessVitamin D levels and SARS-CoV-2 assay results in health care workers in Brazil
- Open Access
- 25 April 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (5)
Relapse of clinical symptoms of COVID-19 or probable reinfection in a laboratory professional: a case report from Northeast Brazil
Healthcare professionals constitute one of the groups that are most vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Herein, we report the case of a non-overweight and non-smoking 42-year-old woman with thrombophilia due to methylenetetrahydrofolate reductase (MTHFR) gene mutation, hereditary renal cysts, and no history of diabetes or arterial hypertension, who presented the first symptoms between 10 and 17 August 2020, with a SARS-CoV-2-positive naso-oropharyngeal swab by qualitative real-time polymerase chain reaction (RT-PCR). However, the result for SARS-CoV-2 immunoglobulin G (IgG) was non-reactive 41 days after (21 September 2020) the onset of symptoms. Nevertheless, on 7 October 2020 (57 days after the first symptoms), the patient presented new symptoms suggestive of COVID-19, with another SARS-CoV-2-positive RT-PCR result, and on 21 October 2020, SARS-CoV-2 immunoglobulin G was positive. Considering this, we interrogated the results to determine whether the case was reinfection or reactivation. This outcome highlights the importance of surveillance over relapses or reinfections.
- 25 April 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (5)
Open AccessRelapse of clinical symptoms of COVID-19 or probable reinfection in a laboratory professional: a case report from Northeast Brazil
Healthcare professionals constitute one of the groups that are most vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Herein, we report the case of a non-overweight and non-smoking 42-year-old woman with thrombophilia due to methylenetetrahydrofolate reductase (MTHFR) gene mutation, hereditary renal cysts, and no history of diabetes or arterial hypertension, who presented the first symptoms between 10 and 17 August 2020, with a SARS-CoV-2-positive naso-oropharyngeal swab by qualitative real-time polymerase chain reaction (RT-PCR). However, the result for SARS-CoV-2 immunoglobulin G (IgG) was non-reactive 41 days after (21 September 2020) the onset of symptoms. Nevertheless, on 7 October 2020 (57 days after the first symptoms), the patient presented new symptoms suggestive of COVID-19, with another SARS-CoV-2-positive RT-PCR result, and on 21 October 2020, SARS-CoV-2 immunoglobulin G was positive. Considering this, we interrogated the results to determine whether the case was reinfection or reactivation. This outcome highlights the importance of surveillance over relapses or reinfections.